as on March 10, 2026 at 4:13 am IST
Day's Low
Day's High
1.21%
Downside
3.64%
Upside
52 Week's Low
52 Week's High
14.35%
Downside
138.91%
Upside
Check Legend Biotech Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.5B
EPS (TTM)
-1.3544
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-181.2M
Revenue (TTM)
909.0M
Profit Margin
-26.37%
Return On Equity TTM
-22.53%
Compare market cap, revenue, PE, and other key metrics of Legend Biotech Corp with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $3.5B | -22.89% | NA | -26.37% | |
| BUY | $42.5B | 132.9% | 137.03 | 8.45% | |
| BUY | $116.0B | 113.37% | 29.85 | 32.94% | |
| NA | $33.3B | NA | 590.43 | 5.37% | |
| BUY | $80.3B | 61.46% | 18.31 | 31.41% |
The Legend Biotech Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Legend Biotech Corp investment value today
Current value as on today
₹59,506
Returns
Returns from Legend Biotech Corp Stock
Dollar Returns*
₹5,734 (+5.73%)
Based on 27 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 27 analysts, 88.89% of analysts recommend a 'BUY' rating for Legend Biotech Corp. Average target price of $58.7
Get share price movements and forecasts by analysts on Legend Biotech Corp.
What analysts predicted
67.7%UPSIDE
Target Price
$58.7
Current Price
$18.96
Analyzed by
27 Analysts
Target
$58.70
Legend Biotech Corp target price $58.7, a slight upside of 67.7% compared to current price of $18.96. According to 27 analysts rating.
Search interest for Legend Biotech Corp Stock has decreased by -54% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 12 November
Wed, 06:02 PM
-Legend Biotech reports Q3 2025 results, highlighting CARVYKTI sales growth and regulatory updates, with a net loss of $39.7 million.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -125.38M → -39.68M (in $), with an average increase of 215.9% per quarter
Revenue Rich
![]()
Revenue is up for the last 5 quarters, 160.20M → 272.33M (in $), with an average increase of 12.1% per quarter
Price Rise
![]()
In the last 7 days, LEGN stock has moved up by 2.9%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 72.4% return, outperforming this stock by 130.1%
Against Peers
![]()
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 31.1% return, outperforming this stock by 77.3%
| Organisation | Legend Biotech Corp |
| Headquarters | 2101 Cottontail Lane, Somerset, NJ, United States, 08873 |
| Industry | Commercial Services |
| CEO | Dr. Ying Huang Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Carlos Santos | Chief Financial Officer |
Ms. Jessie Yeung M.B.A. | Vice President of Finance, Investor & Public Relations |
Ms. Elaine Qian | VP & Global Head of Human Resources |
Dr. Guowei Fang Ph.D. | President of Research & Development |
Mr. Alan S. Bash | President of CARVYKTI® |
Surabhi Verma | Manager of Investor Relations & Corporate Communications |
Dr. Ying Huang Ph.D. | CEO & Director |
Mr. James Pepin J.D. | General Counsel |
Ms. Ananda Elizabeth Martin Esq. | Global Compliance Officer |
Mr. Birk Vanderweeen | Senior Vice President of Global Manufacturing & Supply |
Legend Biotech Corp share price today is $18.96 as on . Legend Biotech Corp share today touched a day high of $19.65 and a low of $18.73.
Legend Biotech Corp share touched a 52 week high of $45.3 on and a 52 week low of $16.24 on . Legend Biotech Corp stock price today i.e. is trending at $18.96,which is 58.14% down from its 52 week high and 16.75% up from its 52 week low.
Legend Biotech Corp market capitalisation is $0.00T as on .
Indian investors can start investing in Legend Biotech Corp (LEGN) shares with as little as ₹92.306 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹923.06 in Legend Biotech Corp stock (as per the Rupee-Dollar exchange rate as on ).
Based on Legend Biotech Corp share’s latest price of $18.96 as on March 9, 2026 at 10:43 pm IST, you will get 0.5274 shares of Legend Biotech Corp. Learn more about
fractional shares .
Legend Biotech Corp stock has given -22.89% share price returns and 26.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?